Brenan Cullimore had a rare genetic condition, Brugada syndrome, that led to cardiac arrest. His wife wants to raise ...

The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...

The study thus extends the limited literature linking methamphetamine and cocaine to VAs and sudden cardiac death. In the ...

Methamphetamine and cocaine use each confer heightened risk for incident ventricular arrhythmias and all-cause mortality, ...

Brenan Cullimore, a 28-year-old medical student, died of cardiac arrest after collapsing during a basketball game with ...

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

VENTRICULAR fibrillation is usually a rapidly fatal arrhythmia that may occur in cardiac patients, in any patient under anesthesia and in drowning and electrocution. In cardiac patients it is a ...

Ventricular fibrillation is a cardiac arrhythmia in which the muscle in the lower chambers of the heart (the ventricles) contracts irregularly and rapidly. The ventricles quiver and are unable to ...

Implantable cardioverter-defibrillator therapy in patients with Brugada syndrome is effective for prevention of fatal arrhythmias.

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle placement.